Role of Hyperplasia Suppressor Gene (HSG) in cell growth.
Role of Hyperplasia Suppressor Gene (HSG) in cell growth.
批准号:
9147302
负责人:
David Schlessinger
金额:
$38.94万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AgeAphidicolinCell AgingCell CycleCell Cycle InhibitionCell LineCell ProliferationCellsDataDown-RegulationGoalsGrowthHumanHyperplasiaMEKsMammalian CellMediatingMembrane ProteinsMemoryMitochondriaMorphologyMusNocodazolePathway interactionsPhosphatidylinositide 3-Kinase InhibitorPhosphorylationPhysiologicalPlayPopulationProductionPropertyProteasome InhibitorProto-Oncogene Proteins c-aktRas/RafRestRoleS PhaseSignal PathwaySirolimusStructure-Activity RelationshipSuppressor GenesT-Cell ActivationT-Cell ReceptorT-LymphocyteWestern BlottingYeastscell agecell growthflyhuman FRAP1 proteininhibitor/antagonistmTOR Inhibitormemory CD4 T lymphocytemitogen-activated protein kinase p38overexpressionperipheral bloodpreventresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have shown recently that Mfn2 overexpression caused growth suppression in multiple cell lines by suppressing Ras-Raf-MEK-ERK signaling pathway. To investigate the physiological relevance of the anti-proliferative properties of Mfn2, we extended our studies to human peripheral blood T cells. We wanted to know what happens to the Mfn2 levels during T cell activation through T cell receptors. Our data have demonstrated that the activation-induced degradation of Mfn2 preceded the cells entry into the cell cycle. Pharmacological inhibitors (LY294002, a PI3 kinase inhibitor; rapamycin, an mTOR inhibitor; and A443654, an AKT inhibitor) that blocked the activation-induced degradation of Mfn2, also blocked the cell cycle. The blockage in Mfn2 degradation was not a general consequence of cell cycle inhibition, since late cell cycle blockers (aphidicolin, an S-phase blocker; and Nocodazole, a G2/M blocker) blocked the cell cycle without preventing the degradation of Mfn2. These data suggest that the activation-induced Mfn2 degradation is a pre-requisite for cells entry into the cell cycle. Over-expression of constitutively active AKT resulted in the downregulation of Mfn2, which can be blocked by a proteasome inhibitor. Akt-mediated downregulation of Mfn2 was via the mTORC1 pathway since (i) this downregulation was blocked by rapamycin, and (ii) over-expression of mTOR caused Mfn2 downregulation. Our data suggested that mTOR was involved in activation-induced ROS production, which in turn activated p38 MAP kinase resulting in the phosphorylation of Mfn2 and subsequent degradation. Collectively, our data suggest that PI3K-AKT-mTOR pathway plays an important role in activation-induced downregulation of Mfn2 and subsequent proliferation of resting T cells.
It is known that T cells from aged mice have deficit in their proliferative capacities. To investigate the status of Mfn2 in the proliferative response of T cells from aged mice, naive and memory CD4+ T cells from young and old mice were activated through T cell receptor for 3 days, and the status of Mfn2 was determined by western blot analysis using whole cell lysates. The degree of activation-induced Mfn2 degradation was much less in memory as compared to nave populations, which correlated with the reduced proliferative capacities of memory as compared to naive populations. We are currently investigating the mechanisms responsible for the altered degradation of Mfn2 in memory populations irrespective of their age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glypican 3 Action In Overgrowth Syndromes
-
批准号:6508426
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development /Applications Of Open Microscopy Environment
-
批准号:6668443
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Role Of Ectodysplasin-a In Skin Appendage Formation
-
批准号:8736579
-
项目类别:
-
资助金额:$68.85万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:8736589
-
项目类别:
-
资助金额:$55.08万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:7592038
-
项目类别:
-
资助金额:$33.1万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:8335890
-
项目类别:
-
资助金额:$37.49万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Role Of Ectodysplasin-a In Skin Appendage Formation
-
批准号:7732268
-
项目类别:
-
资助金额:$41.62万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Developmental Genes in Sebaceous Glands and Keratinocytes
-
批准号:7732282
-
项目类别:
-
资助金额:$33.02万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Systematic analysis of gene regulatory networks
-
批准号:9341859
-
项目类别:
-
资助金额:$16.51万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Spatial Mapping Of Gene Expression Early Mouse Embryo
-
批准号:7132311
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Expression profiling of mouse embryonic and tissue stem cells
-
批准号:8552434
-
项目类别:
-
资助金额:$84.23万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development and maintenance of bioinformatics tools for mouse biology
-
批准号:8552444
-
项目类别:
-
资助金额:$89.77万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Systematic analysis of gene regulatory networks
-
批准号:8736583
-
项目类别:
-
资助金额:$56.59万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Genes Associated With Ovarian Development and Premature Ovarian Failure
-
批准号:9147313
-
项目类别:
-
资助金额:$71.63万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:9549327
-
项目类别:
-
资助金额:$95.22万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development and maintenance of bioinformatics tools for mouse biology
-
批准号:8931569
-
项目类别:
-
资助金额:$69.98万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development And Applications Of The Open Microscopy Envi
-
批准号:7326108
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Heritability and Covariate Traits in Sardinian and Other
-
批准号:7326499
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Genes Associated With Ovarian Development and Premature Ovarian Failure - test
-
批准号:9341858
-
项目类别:
-
资助金额:$66.62万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Glypican 3 Action in Overgrowth Syndromes
-
批准号:6097861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
国内基金
海外基金
靶向DNA聚合酶α的海洋来源新型aphidicolin类二萜结构多样性挖掘及其抗肿瘤作用机制研究
-
批准号:82073763
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:牛四文
-
依托单位:
深海真菌中aphidicolin衍生物的靶向发现
-
批准号:41906104
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2019
-
负责人:夏金梅
-
依托单位:
DNA聚合酶抑制剂(+)-Aphidicolin全合成研究
-
批准号:21062024
-
项目类别:地区科学基金项目
-
资助金额:27.0万元
-
批准年份:2010
-
负责人:赵元鸿
-
依托单位: